Mieloma - Novedades en investigacion mayo 2006 (3)
Fuente y mas informacion:
Thu, 11 May 2006 14:19:10 -0400 (EDT)
Thu, 18 May 2006 15:22:55 -0400 (EDT)
Thu, 25 May 2006 13:09:51 -0500 (CDT)
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/
Myeloma Minute - May 10, 2006
Myeloma Minute - May 18, 2006
Myeloma Minute - May 24, 2006
http://readtheminute.myeloma.org/
Monitoring organ response in amyloidosis
http://www.bloodjournal.org/cgi/con...ourcetype=HWCIT
Morie A. Gertz*
Blood 2006;107 3814
Circulating amyloidogenic free light chains and serum N-termina natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
http://www.bloodjournal.org/cgi/content/abstract/107/10/3854
Giovanni Palladini, Francesca Lavatelli, Paola Russo, Stefano Perlini, Vittorio Perfetti, Tiziana Bosoni, Laura Obici, Arthur R. Bradwell, GianVico Melzi D'Eril, Roberto Fogari, Remigio Moratti, and Giampaolo Merlini
Blood 2006;107 3854-3858
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory Tcells in patients with multiple myeloma
http://www.bloodjournal.org/cgi/con...ourcetype=HWCIT
Marc Beyer, Matthias Kochanek, Thomas Giese, Elmar Endl, Martin R. Weihrauch, Percy A. Knolle, Sabine Classen, and Joachim L. Schultze
Blood 2006;107 3940-3949
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
http://www.bloodjournal.org/cgi/con...ourcetype=HWCIT
Suzanne Trudel, A. Keith Stewart, Eran Rom, Ellen Wei, Zhi Hua Li, Sarit Kotzer, Irina Chumakov, Yossi Singer, Hong Chang, Sheng-Ben Liang, and Avner Yayon
Blood 2006;107 4039-4046
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
http://www.bloodjournal.org/cgi/con...ourcetype=HWCIT
Teru Hideshima, Laurence Catley, Hiroshi Yasui, Kenji Ishitsuka, Noopur Raje, Constantine Mitsiades, Klaus Podar, Nikhil C. Munshi, Dharminder Chauhan, Paul G. Richardson*, and Kenneth C. Anderson*
Blood 2006;107 4053-4062
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma
http://www.bloodjournal.org/cgi/con...ourcetype=HWCIT
Apollina Goel, Angela Dispenzieri, Susan M. Geyer, Suzanne Greiner, Kah-Whye Peng, and Stephen J. Russell
Blood 2006;107 4063-4070
Am J Hematol. 2006 May 5
Prolonged overall survival with second on-demand autologous transplant in multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Elice F, Raimondi R, Tosetto A, D'Emilio A, Di Bona E, Piccin A, Rodeghiero F.
Bone Marrow Transplant. 2006 May
High-dose melphalan (200 mg/m(2)) supported by autologous stem cell transplantation is safe and effective in elderly (>/=65 years) myeloma patients: comparison with younger patients treated on the same protocol
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Jantunen E, Kuittinen T, Penttila K, Lehtonen P, Mahlamaki E, Nousiainen T.
J Support Oncol. 2006 Apr
The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Meehan KR, Fitzmaurice T, Root L, Kimtis E, Patchett L, Hill J.
Integration of global SNP-based mapping and _expression arrays reveals key regions, mechanisms and genes important in the pathogenesis of multiple myeloma
http://www.bloodjournal.org/cgi/con...05496v1?papetoc
Brian A Walker, Paola E Leone, Matthew W Jenner, Cheng Li, David Gonzalez, David C Johnson, Fiona M Ross, Faith E Davies*, and Gareth J Morgan*
Blood published 16 May 2006, 10.1182/blood-2006-02-005496
Frequent gain of chromosome band 1q21 in plasma cell dyscrasias detected by fluorescence in situ hybridization: Incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem cell transplantation
http://www.bloodjournal.org/cgi/con...09910v1?papetoc
Ichiro Hanamura, James P Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffery R Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda-Roman, Frits van Rhee, Federica Cavall, Bart Burington, John Crowley, Guido Tricot*, Bart Barlogie*, and John D Shaughnessy Jr.
Blood published 16 May 2006, 10.1182/blood-2006-03-009910
Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells.
http://www.ncbi.nlm.nih.gov/entrez/...2&dopt=Abstract
Muller CI, Kumagai T, O'kelly J, Seeram NP, Heber D, Koeffler HP.
Leuk Res. 2006 Jan 16; [Epub ahead of print]
Reata Announces RTA 402 Entering Clinical Development; Promising Oral Anticancer Drug Has Unique Preclinical Profile
RTA 402, has received FDA clearance to begin clinical testing in patients with solid tumors, lymphoma, and myeloma.
http://www.prnewswire.com/cgi-bin/s...04335814&EDATE=
A clinical trial has been initiated with this agent at the M. D. Anderson Cancer Center. (from PR Newswire)
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
http://www.bloodjournal.org/cgi/content/abstract/107/6/2432
Siqing Wang, Jing Yang, Jianfei Qian, Michele Wezeman, Larry W. Kwak, and Qing Yi
Blood, 15 March 2006, Vol. 107, No. 6, pp. 2432-2439.
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion
http://www.bloodjournal.org/cgi/content/abstract/107/6/2531
Gian Matteo Rigolin, Chiara Fraulini, Maria Ciccone, Endri Mauro, Anna Maria Bugli, Cristiano De Angeli, Massimo Negrini, Antonio Cuneo, and Gianluigi Castoldi
Blood, 15 March 2006, Vol. 107, No. 6, pp. 2531-2535.
Lenalidomide and Venous Thrombosis in Multiple Myeloma
http://content.nejm.org/cgi/content/short/354/19/2079?query=TOC
New England Journal of Medicine published May 11, 2006, Volume 354:2079-2080
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
http://www.annals.org/cgi/content/abstract/144/10/753
Sook-Bin Woo, DMD; John W. Hellstein, DDS, MS; and John R. Kalmar, DMD, PhD
Annals of Internal Medicine,16 May 2006, Volume 144 Issue 10, Pages 753-761
Bone Marrow Transplant. 2006 May 8
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Saraf S, Chen YH, Dobogai LC, Mahmud N, Peace D, Saunthararajah Y, Hoffman R, Chunduri S, Rondelli D.
Br J Haematol. 2006 Jun
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma
http://www.ncbi.nlm.nih.gov/entrez/...l=pubmed_docsum
Hosing C, Qazilbash MH, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall EJ, McMannis J, Korbling M, Champlin RE.
____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com
Guia de Uso -
http://www.mieloma.com/ayuda/
Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades. 
Foro 
